Biggar Stephen R 4/A
4/A · SYNAGEVA BIOPHARMA CORP · Filed Jan 17, 2012
Insider Transaction Report
Form 4/AAmended
Biggar Stephen R
Director
Transactions
- Award
Stock Option (Right to Buy)
2011-12-20+15,000→ 15,000 totalExercise: $23.00Exp: 2021-12-19→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]This amendment is filed solely to correct a clerical error in the initial filing. In this regard the number of options acquired was incorrectly included in the disposition column rather than the acquisition column.
- [F2]1/36 of the shares subject to this option vest and become exercisable on December 2, 2011 and monthly thereafter.